We are live on ! Find out more
IBIO icon

iBio
IBIO

16 hedge funds and large institutions have $2.05M invested in iBio in 2015 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% more capital invested

Capital invested by funds: $1.99M → $2.05M (+$61K)

0% less ownership

Funds ownership: 0% → 0% (-0%)

20% less funds holding

Funds holding: 20 → 16 (-4)

40% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 5

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

Holders
16
Holders Change
-4
Holders Change %
-20%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
5
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$173K
2
BIT
BlackRock Institutional Trust
California
+$98.3K
3
Northern Trust
Northern Trust
Illinois
+$40.7K
4
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
+$6.78K
5
Citigroup
Citigroup
New York
+$3.39K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$321K
2
Citadel Advisors
Citadel Advisors
Florida
-$54.3K
3
SIM
Spark Investment Management
New York
-$27K
4
EWM
Evercore Wealth Management
New York
-$21K
5
VKH
Virtu KCG Holdings
New York
-$13.6K

IBIO Hedge Fund Activity: Q1 2015 in Review

16 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q1 2015, worth a combined $2.05M — up 3.1% from $1.99M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of IBIO and 2 opened new positions — a net loss of 4 holders — while 5 trimmed existing stakes and 3 added.

The largest buyer was Vanguard Group, adding an estimated $173K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $321K sold.

  • 16 institutional investors held iBio (IBIO) as of Q1 2015, down from 20 in Q4 2014.
  • Funds reported $2.05M of iBio stock for Q1 2015, up 3.1% quarter-over-quarter.
  • 2 funds opened new iBio positions in Q1 2015 and 6 closed out, a net change of -4 holders.
  • The largest iBio buyer in Q1 2015 was Vanguard Group, an estimated $173K added.
  • The largest iBio seller in Q1 2015 was Renaissance Technologies, an estimated $321K sold.

Based on aggregated 13F filings for Q1 2015.